Today’s AI Top Pick: TMDX

7/31/2026 · Highly Shorted Turnaround Deep Rotation screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Today's pick · Highly Shorted Turnaround Deep RotationTMDXBUY NOW8.6 / 107/31/2026

TransMedics (TMDX) is the cleanest setup in the entire pool because it's the rare name where solid, real fundamentals AND every timeframe of the forecast tape agree. On fundamentals it's a genuine growth compounder that got mispriced: trailing PE 17.47, fwd PE 24.81, ROE 45.22%, profit margin 27.04%, sales +30.24% YoY, EPS growth next year +67.77%, analyst recom 1.75, and it's already down -37.42% YTD / -29.31% 1Y with 23.23% short float. That's the exact 'baby thrown out with the bathwater' profile the screen is designed to catch, and the fundamental_score of 6.75 backs it up. The tape confirms rather than fights the fundamentals. All four horizons of forecasts point the same direction: 1h fc_short/mid/long +23.52/+28.42/+28.18, 4h +37.43/+24.11/+31.07, 1d +21.13/+51.63/+37.75, and 1wk +0.84/+3.61/+19.94. Bullish_prob is 1.0 and near_term_bullish is 1.0 — the strongest confluence in the list. Contrast this with PGY (highest fundamental score of 8 but 1h/4h forecasts are -17 to -19% and price sits at 94.74% of the weekly range — you'd be chasing) and PSIX (huge forecasts but 1wk fc_long is -31%, a red flag). Entry timing today is favorable rather than chasing. The stock is still -37.26% off the 21-week high and only at 23.68% of the weekly range, so we're buying in the lower third of the medium-term range, not the top. Short-term positioning at 90–94% of 1h/1d ranges means small pullback risk, but drawdown from the 21-bar high is only -0.67% to -1.30% — the stock is trending, not extended parabolic. Recent Chartmill/SeekingAlpha coverage flags it as 'affordable growth stock with strong earnings momentum,' and there's no negative catalyst headline (no dilution, no legal issue, no guidance cut). Why today over waiting: the multi-timeframe alignment is rare, the fundamental screen is clean, and the medium-term forecast (1d fc_mid +51.63%) implies the market is starting to re-rate the name. Waiting for a deeper pullback risks missing the mean-reversion leg while the shorts (23.23% of float) start covering. Size in today, add on any dip toward the 4h VWAP.

Entry zone

$75.50–$77.80 (buy half at market ~$77.48, add other half on dip to $75.50 near the 4h/1d midrange)

Stop loss

$69.90 (below the recent 4h consolidation and roughly -10% — invalidates the near-term bullish forecast)

First target

$93–$95 (aligns with 1d fc_short +21% and analyst upside of ~$111 haircut)

Longer target

$115–$120 (1d fc_mid +51.6% and targetUpsidePct 44% from current, plus short-squeeze accelerant)

Risks

Healthcare/medtech sentiment risk — RxSight earnings preview flagged Q2 decline in the space, so a soft print could drag TMDX sympathetically
Short-term range extension: at 90.3% (4h) and 94.3% (1d) of range, a 3–5% mean-reversion dip is plausible before the next leg
1wk timeframe still shows -37.26% from high — if the weekly downtrend re-asserts, stop at $69.90 is essential
23.23% short float cuts both ways: fuel for a squeeze, but also implies smart-money conviction against the name
Debt/Equity 1.75 is elevated for a medtech; any rate-driven risk-off would hit this harder than peers

Honorable mentions

PSIXBest deep-value setup: PE 6.28, ROE 75.67, profit margin 14.28, and forecasts across 1h/4h/1d are massive (+72% to +142% on fc_long). Only reason it's #2 not #1 is the 1wk fc_long of -31% and pos_in_range of 0% on weekly — the base is still forming. New CEO announced Aug 17 is a potential catalyst.

CELHHighest fundamental_score at 7.5 with sales +123% YoY and 1d fc_mid +49.83%. Docked to #3 because near_term_bullish is only 0.4, 1h forecasts are flat/negative, and earnings Aug 6 is a binary event — better to wait for the print or buy pullback.

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	TMDX	BUY NOW	8.6	All four timeframes bullish, fund score 6.75, PE 17, ROE 45%, still -37% from weekly high — cleanest confluence in the pool.
2	PSIX	BUY NOW	7.9	PE 6.28, ROE 75%, forecasts +72% to +142% on 1h/4h/1d; weekly base still forming but risk/reward exceptional.
3	CELH	BUY PULLBACK	7.2	Best fundamentals (fund score 7.5) but earnings Aug 6 is binary and 1h/4h short forecasts weak — wait for print or dip.
4	BIRK	BUY NOW	6.7	Fund score 7.5, near_term_bullish 0.8, position only 11.64% of daily range — low-vol grind higher, modest forecast magnitudes.
5	CWH	BUY PULLBACK	6.5	1d fc_long +75.7% and 1wk +158.4% but debtEq 15.21 is scary; Q2 print just dropped — wait for reaction.
6	MP	BUY PULLBACK	6.3	Goldman AI mine-to-magnet thesis catalyst, 1h/4h fc +50%, but 1wk forecasts all negative — buy the dip.
7	WING	BUY PULLBACK	6.1	1d fc_mid +65%, at 2.66% of daily range — deep oversold, but Jersey Mike's IPO overhang and weak weekly forecast.
8	MNDY	BUY PULLBACK	6.0	1d fc_long +58.5% and 1wk +100.8% eye-popping, but at 100% of weekly range — chasing risk after 20% layoff news.
9	PGY	WAIT	5.7	Best fund score (8) but 1h/4h forecasts -17 to -19% and at 94.7% of weekly range — post-earnings pop, don't chase.
10	KVYO	BUY PULLBACK	5.6	Citi $34 PT raise, fwd PE 17.66, all-timeframe positive mid/long forecasts, near-term bullish only 0.4.
11	ASST	BUY NOW	5.5	BTC treasury play, near_term_bullish 1.0, 1h/4h/1d forecasts +30–62%; Vanguard buying is a real bid.
12	TTAN	WAIT	5.3	Forecasts turning negative on 1h/4h (-12 to -18%), CFO insider sale — momentum fading.
13	UPXI	BUY PULLBACK	5.2	Explosive 1wk fc_long +1406% is an outlier; solid 1h/4h fc +50–78% but $63M cap = high risk.
14	CRWV	WAIT	5.1	AI narrative solid, sales +129%, but Aschenbrenner selling stakes is a headwind; no bullish_prob score.
15	BTBT	BUY PULLBACK	5.0	Near_term_bullish 1.0, all forecasts positive, BTC beta play — fwd PE 142 is a warning.
16	RDW	WAIT	4.9	1h fc +82% but 4h/1wk long forecasts negative — divergence signals fade risk.
17	PROP	AVOID	4.8	4h fc +116% looks like an outlier; debtEq 1222 and roe -700% are red flags.
18	PCT	BUY PULLBACK	4.7	1d fc_mid +51.8%, gross margin -1124% and debtEq 99.58 — speculative only.
19	VOYG	BUY PULLBACK	4.6	Sandia contract catalyst, 1h fc +85%, but at 100% of 1h range — wait for dip.
20	TNXP	AVOID	4.5	1wk fc of +50,000% is a data outlier; only two timeframes available — untrustworthy signal.
21	ASPI	BUY PULLBACK	4.5	Noble Africa listing catalyst, 1d fc_mid +69.8%, but weekly forecasts all negative.
22	FIP	WAIT	4.4	Positive 1h/4h forecasts +25–43%, but Citizens lowered PT to $10; muted setup.
23	PDYN	WAIT	4.3	USAF contract option positive, but 1wk fc_long -37% and near_term_bullish only 0.2.
24	KULR	AVOID	4.2	Selling BTC treasury for cash is dilutive signal; near_term_bullish 0.2 and 1d fc_short -18%.
25	INV	WAIT	4.1	1h fc +96% but 4h -30% recent, operMargin -3586% — pure lottery ticket.
26	DFDV	AVOID	4.0	Solana treasury proxy with -47% YTD, near_term_bullish 0 and 1wk forecasts all negative.
27	FRMM	WAIT	3.9	1d fc_long +20% modest, only 2 timeframes, shortFloat 48% — squeeze risk both ways.
28	SAIL	WAIT	3.8	Insider selling, forecasts all negative on 1h (-16 to -18%); Entro acquisition not yet accretive.
29	FLWS	AVOID	3.5	NY AG $375K settlement on deceptive subscriptions is a landmine; near_term_bullish 0.
30	TDUP	AVOID	3.5	StockStory flagged as consumer stock to avoid; modest forecasts and 1wk fc negative.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord